It was initially identified in X-linked agammaglobulinemia (XLA), a rare immune deficiency disorder (Akinleye et al., 2013) mediated by a loss-of-function BTK mutation, resulting in the absence of B cells (Wiestner, 2013). Here, BTK is linked to Bruton-type agammaglobulinemia.